Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

CSBR

Champions Oncology (CSBR)

Champions Oncology Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CSBR
DataHoraFonteTítuloCódigoCompanhia
06/05/202420:46Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CSBRChampions Oncology Inc
12/02/202423:12Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CSBRChampions Oncology Inc
16/01/202413:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSBRChampions Oncology Inc
13/12/202318:47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CSBRChampions Oncology Inc
12/12/202318:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CSBRChampions Oncology Inc
12/12/202307:50IH Market NewsHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and MoreNASDAQ:CSBRChampions Oncology Inc
28/08/202316:14Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CSBRChampions Oncology Inc
28/08/202316:12Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CSBRChampions Oncology Inc
24/07/202317:17Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CSBRChampions Oncology Inc
05/04/202312:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CSBRChampions Oncology Inc
21/03/202313:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CSBRChampions Oncology Inc
12/09/202217:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CSBRChampions Oncology Inc
31/08/202210:29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CSBRChampions Oncology Inc
29/08/202216:17Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)NASDAQ:CSBRChampions Oncology Inc
22/07/202217:29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CSBRChampions Oncology Inc
14/02/202212:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CSBRChampions Oncology Inc
23/07/202114:53Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CSBRChampions Oncology Inc
11/09/202007:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CSBRChampions Oncology Inc
10/12/201819:30PR Newswire (US)Champions Oncology to Announce Second Quarter Financial Results on Monday, December 17, 2018NASDAQ:CSBRChampions Oncology Inc
07/11/201811:30PR Newswire (US)Champions Oncology to Participate in the 9th Annual Craig-Hallum Alpha Select ConferenceNASDAQ:CSBRChampions Oncology Inc
13/09/201817:05PR Newswire (US)Champions Oncology Reports Record Quarterly Revenue of $6.2 MillionNASDAQ:CSBRChampions Oncology Inc
13/09/201809:30PR Newswire (US)Champions Oncology to Participate at the Janney Montgomery Scott Healthcare Conference 2018 in New YorkNASDAQ:CSBRChampions Oncology Inc
28/08/201809:30PR Newswire (US)Champions Oncology to Announce First Quarter Financial Results on Thursday, September 13, 2018NASDAQ:CSBRChampions Oncology Inc
08/08/201809:30PR Newswire (US)Champions Oncology Granted Full Accreditation by the AAALACNASDAQ:CSBRChampions Oncology Inc
26/07/201817:02PR Newswire (US)Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018NASDAQ:CSBRChampions Oncology Inc
12/07/201809:30PR Newswire (US)Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 26, 2018NASDAQ:CSBRChampions Oncology Inc
18/06/201809:30PR Newswire (US)Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PD...NASDAQ:CSBRChampions Oncology Inc
03/05/201809:30PR Newswire (US)Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9thNASDAQ:CSBRChampions Oncology Inc
01/05/201809:30PR Newswire (US)Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology ResearchNASDAQ:CSBRChampions Oncology Inc
04/04/201809:30PR Newswire (US)Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex HouseNASDAQ:CSBRChampions Oncology Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CSBR